Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV
about
The Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-AnalysisDesirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We NeedThe potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trialsSingle-Tablet Regimens in HIV TherapyGlobal response to HIV: treatment as prevention, or treatment for treatment?Once-Daily, Single-Tablet Regimens For the Treatment of HIV-1 InfectionComparison of HIV outcomes for patients linked at hospital versus community-based clinicsThe HIV Care Continuum: Changes over Time in Retention in Care and Viral SuppressionHigh Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy.Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States.Health Outcomes of HIV-Infected People with Mental Illness.Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment RegimensSingle Tablet Regimen Usage and Efficacy in the Treatment of HIV Infection in AustraliaEffectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.Correlates of Combination Antiretroviral Adherence Among Recently Diagnosed Older HIV-Infected Adults Between 50 and 64 yearsLower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials.Emerging antiretroviral drugs.Addressing the value of novel therapies in chemotherapy-induced nausea and vomiting.Abacavir/dolutegravir/lamivudine single-tablet regimen: a review of its use in HIV-1 infection.Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in FranceAntiretroviral Treatment Switching and Its Association With Economic Outcomes and Adverse Treatment Effects Among Commercially Insured and Medicaid-Enrolled Patients With HIV in the United States.Barriers to HIV Medication Adherence as a Function of Regimen Simplification.Abacavir + dolutegravir + lamivudine for the treatment of HIV.Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.Adherence to combination antiretroviral treatment and clinical outcomes in a Medicaid sample of older HIV-infected adults.The association between combination antiretroviral adherence and AIDS-defining conditions at HIV diagnosis.Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries.The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States.Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI.Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database.Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study.Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients.Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study.International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UKA meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIVImpact of antiepileptic-drug treatment burden on health-care-resource utilization and costs
P2860
Q26865049-A9EFFBFF-11C5-48E9-BF81-5FFD4A62AE15Q28067411-CB695C67-F612-4BB3-A4AA-0816786537AFQ28087336-9B7A9771-BE37-4A76-AEA0-D30CAE3BD859Q33939110-FF68D44F-ADE6-4AA6-951B-7975C6079A82Q34077723-ADB511BD-3A97-46E2-8753-03ECFB85A7F6Q34976284-1E3434B5-E9F6-406E-8996-52AE9EF323A1Q35156672-AA88B683-9F14-4C50-9EC1-2DAAC3842C20Q35666922-A362939F-FA8B-4AA0-8742-37E4ED0D7FF6Q35808100-827A92E0-E545-43A4-8070-4745DEED610BQ35903617-C74BA8D9-3484-4792-8BA2-2141B1CF5609Q35925058-0A50EE41-56B1-4334-9C83-3B84958D7D67Q36206941-CFE288EF-294D-42EE-9BA4-DA4D1CEE387FQ36208913-ABB5500E-15C0-4675-8E47-14F6474F1E16Q36267762-F4DD3BF6-33F2-407D-BB03-5F0BACC8C837Q37184269-D13F132D-7B35-440D-8073-1A2383BBC7CBQ37696578-A45DE9AD-50C8-4826-BFF9-1DDDEFF9234EQ38167382-6B905BFA-426E-465F-9A78-BFF0BF78CD27Q38250191-D3C01B1D-1160-4321-9891-223EC1AE97B0Q38362394-6494898A-41EF-443D-AE28-5406AAE8939BQ38661423-047A6B8E-FC11-4634-B0AA-325B728BB3D4Q38903685-29884A5F-1FC9-4A9F-A91D-9EB1BC2F413CQ38924226-B34C8D13-33C7-466F-B622-B1DF8CB3E6B6Q38951349-B341086D-9A38-4147-96F4-75AFD69F970FQ39060951-5E6CE2F0-D77C-4EE3-8551-DB0B8C23C737Q39148090-581C92DD-9283-42F5-A11C-1AEF0B76C869Q39990988-FFFAD403-F866-4082-8401-A95DA73A9B7CQ40138163-DAEA11F1-E28A-4D93-9FFC-963109C08E62Q40179664-BFBCB8A9-1EF0-4377-B580-8FA4EFCACEE3Q40194507-5B926BE7-A04A-44A3-AEF1-87C45667B18BQ41294004-64F1DC1E-B360-4518-AC71-5CD09D047404Q47136520-356EA4E2-59EE-42DF-A215-E4869628C292Q47554342-741B7A16-C99D-49A2-A5D3-E11EFD99D800Q53286047-DF6D4C04-EADD-4F11-B7DF-4A28B76C7E97Q56762706-5A51195B-6DE9-4FDD-A010-895ADD16A346Q58092550-929E1AFF-FE98-4120-B052-CDF773B7CF20Q58694702-C80890B9-2549-4EBC-8C10-A8104CC6A586
P2860
Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association between daily anti ...... S medicaid population with HIV
@en
Association between daily anti ...... medicaid population with HIV.
@nl
type
label
Association between daily anti ...... S medicaid population with HIV
@en
Association between daily anti ...... medicaid population with HIV.
@nl
prefLabel
Association between daily anti ...... S medicaid population with HIV
@en
Association between daily anti ...... medicaid population with HIV.
@nl
P2093
P2860
P921
P1433
P1476
Association between daily anti ...... S medicaid population with HIV
@en
P2093
Calvin J Cohen
Juliana L Meyers
Keith L Davis
P2860
P356
10.1136/BMJOPEN-2013-003028
P577
2013-08-01T00:00:00Z